What is the relevance of this therapy in the context of current needs?

Constituting Non-Artemisinin-based Combination Therapy (N-ACT), it is being developed to meet the challenge of artemisinin resistance.

Last update on 05.05.2016 by Dr. Björn Lindemann.

Go back